STOCK TITAN

Destination XL Group, Inc. Recommends DXL Stockholders Reject Zodiac Partners II's Revised, Unsolicited Tender Offer and NOT Tender Their Shares

(Very High)
(Neutral)
Tags

Destination XL Group (NASDAQ: DXLG) announced that its Board, after consulting external legal and financial advisors, unanimously recommends that stockholders reject Zodiac Partners II’s revised, unsolicited tender offer of $0.84 per share in cash and not tender their shares.

The Board believes the modestly increased offer still undervalues DXL and, according to the Board, Zodiac’s repeated offers are highly conditional and opportunistic. Stockholders who already tendered may withdraw their shares any time before the offer expires at 5:00 PM ET on July 24, 2026. The Board’s formal recommendation is detailed in a Schedule 14D-9 filed with the SEC.

Loading...
Loading translation...

Positive

  • Board unanimously recommends rejecting $0.84 per share tender offer
  • External legal and financial advisors engaged to review Zodiac’s revised offer
  • Stockholders may withdraw tendered shares until 5:00 PM ET on July 24, 2026
  • Formal recommendation issued via Schedule 14D-9 filing with the SEC

Negative

  • Revised unsolicited tender offer at $0.84 per share for all outstanding shares
  • Board characterizes Zodiac’s repeated offers as highly conditional and opportunistic

News Market Reaction – DXLG

+0.73%
+0.73% Session close to close

In the Jul 9 session, DXLG gained 0.73%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

DXL’s Board formally advised stockholders to reject Zodiac’s revised $0.84 per-share tender offer an...
Analysis

DXL’s Board formally advised stockholders to reject Zodiac’s revised $0.84 per-share tender offer and not tender, ahead of the offer’s July 24, 2026 expiration, reinforcing its stance that the proposal undervalues the company versus its standalone prospects.

Key Figures

Revised offer price: $0.84 per share Offer expiration: 5:00 PM ET on July 24, 2026
2 metrics
Revised offer price $0.84 per share Cash tender offer by Zodiac Partners II for all outstanding DXL shares
Offer expiration 5:00 PM ET on July 24, 2026 Deadline for stockholders to tender or withdraw shares under the Revised Offer

Historical Context

5 past events · Latest: Jun 23 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 23 Revised tender review Neutral -2.8% Board announced review of revised $0.84 per share Zodiac tender offer.
Jun 03 Merger update Negative -1.5% Board said existing FullBeauty merger terms are not in stockholders’ best interests.
Jun 03 Q1 2026 earnings Negative -1.5% Reported Q1 2026 sales decline and net loss with negative adjusted EBITDA.
May 26 Tender offer rejection Neutral +0.3% Board recommended rejecting $0.82 Zodiac tender offer and not tendering shares.
May 22 Initial tender review Positive +5.6% Company disclosed review of unsolicited $0.82 per share cash tender offer.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent tender-offer and merger headlines have produced mixed, mostly modest share-price reactions for DXL.

Key Terms

tender offer, schedule 14d-9, solicitation/recommendation statement
3 terms
tender offer financial
"revised, unsolicited tender offer to acquire all outstanding shares of DXL for $0.84"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
View in glossary
schedule 14d-9 regulatory
"Solicitation/Recommendation Statement on Schedule 14D-9 filed today with the U.S."
Schedule 14D-9 is a filing with the U.S. Securities and Exchange Commission in which a company publicly states its response and recommendation to an outside bid to buy its shares (a tender offer). Think of it as the company’s advisory note to shareholders explaining whether to sell, keep, or seek alternatives, and why, with facts and reasoning. Investors rely on it to gauge management’s view of the offer’s fairness and the likely impact on value and strategy.
solicitation/recommendation statement regulatory
"The DXL Board issued its formal recommendation with respect to Zodiac’s Offer in a Solicitation/Recommendation Statement"
A solicitation/recommendation statement is a public message from a company, board member, shareholder or advisor that asks investors to take a specific action—such as voting a proxy, tendering shares, or accepting or rejecting an offer—and explains which choice the issuer recommends. It matters to investors because these statements aim to shape outcomes that affect ownership, control or value, and they are often subject to disclosure rules so readers can judge the source’s motives and reliability; think of it like a persuasive letter that also must show who wrote it and why.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CANTON, Mass., July 08, 2026 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (“DXL”) (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and shoes, today announced that its Board of Directors, following a review with external legal and financial advisors, unanimously recommends that stockholders reject the revised, unsolicited tender offer to acquire all outstanding shares of DXL for $0.84 per share in cash (the “Revised Offer”) announced by Zodiac Partners II, LLC (“Zodiac”) on June 23, 2026, and not tender their shares.

“The DXL Board of Directors remains committed to maximizing stockholder value and acting in the best interests of all DXL stakeholders,” said Lionel Conacher, Chairman of the Board of DXL. “After careful review of Zodiac’s revised proposal, the Board unanimously concluded that the modest increase in consideration still undervalues DXL and is not in the best interests of our stockholders. The Board reiterated its belief that Zodiac’s repeated offers are highly conditional, opportunistic and seemingly timed to deliberately exploit a period of market dislocation. We therefore recommend that stockholders reject the Revised Offer and do not tender their shares.”

DXL stockholders who have already tendered their shares may withdraw them at any point prior to the expiration of the offer at 5:00 PM ET on July 24, 2026.

The DXL Board issued its formal recommendation with respect to Zodiac’s Offer in a Solicitation/Recommendation Statement on Schedule 14D-9 filed today with the U.S. Securities and Exchange Commission (“SEC”).

Advisors
Guggenheim Securities, LLC is acting as financial advisor to DXL, Greenberg Traurig, LLP is acting as its legal advisor and Joele Frank, Wilkinson Brimmer Katcher is serving as its strategic communications advisor.

About Destination XL Group, Inc.
Destination XL Group, Inc. is the leading retailer of Men’s Big + Tall apparel that provides the Big + Tall man the freedom to choose his own style. Subsidiaries of Destination XL Group, Inc. operate DXL Big + Tall retail and outlet stores and Casual Male XL retail and outlet stores throughout the United States, and an e-commerce website, DXL.COM, and mobile app, which offer a multi-channel solution similar to the DXL store experience with the most extensive selection of online products available anywhere for Big + Tall men. The Company is headquartered in Canton, Massachusetts, and its common stock is listed on the Nasdaq Global Market under the symbol “DXLG.” For more information, please visit the Company's investor relations website: https://investor.dxl.com.

Investor Contact:
Investor.relations@dxlg.com
603-933-0541

Important Information about the Zodiac Tender Offer and Where to Find It
DXL intends to file a solicitation/recommendation statement on Schedule 14D-9 with respect to the tender offer with the Securities and Exchange Commission (the “SEC”) within 10 business days of the commencement of the Zodiac tender offer. INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE SOLICITATION/RECOMMENDATION STATEMENT AND ANY OTHER RELEVANT DOCUMENTS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TENDER OFFER. Investors and security holders may obtain free copies of the solicitation/recommendation statement (when available) as well as other filings by DXL, without charge, at the SEC’s website, http://www.sec.gov, or by accessing DXL’s website at investor.dxl.com. In addition, documents filed with the SEC by DXL will be available free of charge by writing to DXL at 555 Turnpike Street, Canton, Massachusetts 02021, Attention: Corporate Secretary.

Forward-Looking Statements
In addition to historical information, this document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, including statements regarding the DXL Board of Director’s commitment to maximizing shareholder value and taking actions that are in the best interest of the Company and its shareholders, are based on current expectations, estimates and beliefs of DXL management. Words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “seeks” and variations of such words and similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature. With respect to any such forward-looking statements, DXL claims the protection provided for in the Private Securities Litigation Reform Act of 1995. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our expectations will be attained and therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. These forward-looking statements could be affected by factors including, without limitation, the risks and factors detailed in reports filed with the SEC by DXL from time to time, including those discussed under the heading “Risk Factors” in DXL’s most recently filed Annual Report on Form 10-K. These documents are available through our website or through the SEC’s Electronic Data Gathering and Analysis Retrieval (EDGAR) system at http://www.sec.gov. DXL does not undertake any duty to update any forward-looking statements contained herein, whether as a result of new information or developments, future events or otherwise, except as required by law.


FAQ

What did Destination XL (NASDAQ: DXLG) announce about Zodiac’s revised tender offer on July 8, 2026?

Destination XL’s Board unanimously recommended that stockholders reject Zodiac Partners II’s revised, unsolicited tender offer for DXLG shares. According to Destination XL, the $0.84 per share cash offer, even after a modest increase, still undervalues the company and is not in stockholders’ best interests.

What is the price and key term of Zodiac Partners II’s revised tender offer for DXLG shares?

Zodiac’s revised offer proposes to acquire all outstanding Destination XL shares for $0.84 per share in cash. According to Destination XL, this unsolicited tender offer is highly conditional, covers all outstanding shares, and is currently set to expire at 5:00 PM ET on July 24, 2026.

Why does the Destination XL Board believe the $0.84 DXLG tender offer undervalues the company?

The Board concluded the modest increase in Zodiac’s consideration still undervalues Destination XL and its prospects. According to Destination XL, directors remain committed to maximizing stockholder value and view Zodiac’s repeated offers as highly conditional, opportunistic, and timed to exploit a period of market dislocation.

Until when can Destination XL (DXLG) stockholders withdraw shares tendered into Zodiac’s offer?

Stockholders can withdraw any previously tendered Destination XL shares at any time before the offer’s expiration. According to Destination XL, the revised tender offer from Zodiac Partners II is currently scheduled to expire at 5:00 PM ET on July 24, 2026, unless extended or terminated.

How is Destination XL advising DXLG investors who have not yet responded to Zodiac’s tender offer?

Destination XL’s Board recommends that all stockholders reject Zodiac’s revised tender offer and not tender their shares. According to Destination XL, directors unanimously determined the $0.84 per share cash offer undervalues the company and is not in the best interests of its stockholders.

What formal steps did Destination XL take regarding its recommendation on the DXLG tender offer?

Destination XL issued a formal recommendation on Zodiac’s offer through a Schedule 14D-9 filed with the SEC. According to Destination XL, the filing details the Board’s unanimous rejection of the $0.84 per share revised tender offer after consultation with external legal and financial advisors.